1
|
Molderings GJ, Dumoulin FL, Homann J, Sido B, Textor J, Mücke M, Qagish GJ, Barion R, Raithel M, Klingmüller D, Schäfer VS, Hertfelder HJ, Berdel D, Tridente G, Weinstock LB, Afrin LB. Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness. Naunyn Schmiedebergs Arch Pharmacol 2020; 393:1573-1580. [PMID: 32377770 PMCID: PMC7419348 DOI: 10.1007/s00210-020-01886-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Accepted: 04/24/2020] [Indexed: 12/17/2022]
Abstract
Omalizumab is an effective therapeutic humanized murine IgE antibody in many cases of primary systemic mast cell activation disease (MCAD). The present study should enable the clinician to recognize when treatment of MCAD with omalizumab is contraindicated because of the potential risk of severe serum sickness and to report our successful therapeutic strategy for such adverse event (AE). Our clinical observations, a review of the literature including the event reports in the FDA AE Reporting System, the European Medicines Agency Eudra-Vigilance databases (preferred search terms: omalizumab, Xolair®, and serum sickness) and information from the manufacturer’s Novartis database were used. Omalizumab therapy may be more likely to cause serum sickness than previously thought. In patients with regular adrenal function, serum sickness can occur after 3 to 10 days which resolves after the antigen and circulating immune complexes are cleared. If the symptoms do not resolve within a week, injection of 20 to 40 mg of prednisolone on two consecutive days could be given. However, in MCAD patients whose adrenal cortical function is completely suppressed by exogenous glucocorticoid therapy, there is a high risk that serum sickness will be masked by the MCAD and evolve in a severe form with pronounced damage of organs and tissues, potentially leading to death. Therefore, before the application of the first omalizumab dose, it is important to ensure that the function of the adrenal cortex is not significantly limited so that any occurring type III allergy can be self-limiting.
Collapse
Affiliation(s)
- G J Molderings
- Institute of Human Genetics, University Hospital Bonn, Venusberg-Campus 1, D-53127, Bonn, Germany.
| | - F L Dumoulin
- Department of Internal Medicine, Gemeinschaftskrankenhaus Bonn, Bonn, Germany
| | - J Homann
- Department of Internal Medicine, Gemeinschaftskrankenhaus Bonn, Bonn, Germany
| | - B Sido
- Department of General and Visceral Surgery, Gemeinschaftskrankenhaus Bonn, Bonn, Germany
| | - J Textor
- Department of Radiology, Gemeinschaftskrankenhaus Bonn, Bonn, Germany
| | - M Mücke
- Center for Rare Diseases, University Hospital Bonn, Bonn, Germany
| | - G J Qagish
- Medical Office for Internal Medicine, Meckenheim, Germany
| | - R Barion
- Medical Office for Diabetology, Niederkassel, Rheidt, Germany
| | - M Raithel
- Malteser Waldkrankenhaus St. Marien, Medical Clinic II, Erlangen, Germany
| | - D Klingmüller
- Department of Endocrinology, University Hospital Bonn, Bonn, Germany
| | - V S Schäfer
- Department of Rheumatology and Clinical Immunology, Clinic for Internal Medicine III, University Hospital Bonn, Bonn, Germany
| | - H J Hertfelder
- Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany
| | - D Berdel
- Marien Hospital Wesel, Wesel, Germany
| | | | - L B Weinstock
- Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63141, USA
| | - L B Afrin
- Armonk Integrative Medicine, Hematology/Oncology, Purchase, New York, NY, 10577, USA
| |
Collapse
|
2
|
Dipasquale B, Colombatti M, Tridente G. Morphological Heterogeneity and Phenotype Modifications during Long Term in Vitro Cultures of Six New Human Glioblastoma Cell Lines. Tumori 2018; 76:172-8. [PMID: 2330609 DOI: 10.1177/030089169007600204] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Long term in vitro cultures of six human malignant gliomas were established to obtain permanent lines and to assess, under conditions of prolonged culture, changes in morphology and phenotype of neoplastic cells and the extent of these modifications. We analyzed expression of the following markers by immunocytochemistry: glioma-specific antigens (GE2 and CG12), fibronectin, intermediate filaments (GFAP, vimentin, neurofilaments), class I and II histocompatibility antigens (HLA-ABC and HLA-DR), growth factor and receptor (aTGF and EGF-receptor), proliferation-associated antigen (Ki-67). Strong and stable staining with the two antiglioma monoclonal antibodies (GE2 and CG12) was seen, with coexpression of GFAP and fibronectin in five of six cell lines (after 20 passages) and presence of vimentin and neurofilaments. HLA-DR expression was heterogeneous, with a peculiar intracellular compartmentation in four of six cell lines. Cells showed clear cytoplasmic positivity for aTGF and strong membrane staining for EGF-receptor. In previous studies we showed that these cell lines have increased copies of chromosome 7; therefore we speculate that an autocrine pathway of stimulation may maintain the neoplastic growth. The percentage of Ki-67 positive proliferating cells ranged from 40 to > 60%, depending on cell line and passage. A slight decrease in the positivity of some markers (GFAP, vimentin and HLA-DR in 2/6 cell lines) was observed after prolonged in vitro culture (> 12 months), but morphophenotypic modifications, established within a few passages after explanation, were maintained with time. A clonogenic assay showed values of plating efficiency (PE) higher than corresponding values of other similar cell lines with a tendency to increase in the late passages. PE and Ki-67 positivity were not associated with tumorigenicity into nude mice (except the Hu 197 cell line). These results indicate that, in culture, all six cell lines acquired stable morphology, a well defined antigenic phenotype and high growth rate. Further studies will be performed on these permanent cell lines to clarify differentiation steps of malignant gliomas.
Collapse
Affiliation(s)
- B Dipasquale
- Istituto di Scienze Immunologiche, University of Verona, Italy
| | | | | |
Collapse
|
3
|
Abstract
Bone marrow from C57BL mice with myeloid leukemia induced by Graffi virus has been studied with the electron microscope by ultrathin section and negative stain techniques. Virus particles were usually found in different types of bone marrow cells as well as in extracellular spaces. However, the highest number of particles in various stages of maturation was observed in the cytoplasm of megakaryocytes. Two main types of virus particle were found: the immature Al particle and the mature C particle. They were morphologically indistinguishable from other murine leukemogenic viruses. In partially purified preparations studied by negative staining, some of the particles which were not penetrated by PTA, frequently showed a tail-like structure of variable length. In ultrathin sections, particles were found to originate by budding from the cell membranes. Budding of particles was particularly evident in megakaryocytes and especially within the granules and cytoplasmic vesicles or in connection with the platelet demarcating membranes. The findings of a high number of virus particles in all stages of maturation in megakaryocytes together with a certain degree of megakaryocytosis observed in the bone marrow suggest that this type of cell is possibly one of the main source of production of the virus. A few particles resembling morphologically mycoplasma were detected within the cytoplasm of some immature bone marrow cells.
Collapse
|
4
|
Abstract
These experiments were designed to evaluate the specificity of cytotoxic antibodies for normal and leukemic leukocytes from mice with different genotypes. C57BL and C3Hf/Gs mice were immunized with allogeneic splenic cells from C3Hf/Gs, C57BL and (C3Hf/Gs x CBA T6T6) F1 donors. The animals were injected intraperitoneally once a week for 6–7 weeks and serum was obtained 7 days after the last injection. The cytotoxic effect of the sera on leukocytes was evaluated using the Terasaki test, which is based on direct phase contrast observation of refraction modification in damaged cellular elements. By using donors and recipients with dissimilar H-2 locus, an increase in the cytotoxic index was observed which was related to the number of immunizing injections. Values were fairly uniform for the different combinations tested. The maximum antibody titer was obtained 7 days after the last injection with notable decrease after 14 and 30 days. Cross tests between antisera and leukocytes with the same or different H-2 allele have demonstrated a high specificity of the isoantisera for the different H-2 locus alleles (k, b). In another group of experiments, the effect of isoantisera on leukocytes from animals with generalized leukemia was tested. The leukemia was induced by inoculation at birth with either Graffi or Gross virus. In the 12 cases studied, the cytotoxic effect on leukemic cells was always less than on normal cells of the same strain. Finally, a group of experiments was carried out using leukemic anti-leukocyte sera obtained by immunizing C57BL animals with cells derived from 2 Graffi virus-induced leukemias grafted into (C3Hf/Gs x CBA T6T6) F1 mice. These sera presented maximum cytotoxic index values on leukocytes of (C3Hf/Gs x CBA T6T6) F1 animals with Graffi virus-induced leukemia. Lower values were observed for normal leukocytes of the same strain. (C3Hf/Gs x CBA T6T6) F1 cells originating from Gross virus-induced leukemia were less sensitive to these sera, not only in comparison with Graffi virus-induced leukemia leukocytes but with normal (C3Hf/Gs x CBA T6T6) F1 leukocytes as well. It was also possible to demonstrate positivity in the cytotoxic response with C57BL leukemic leukocytes (Graffi virus-induced). These data seem to indicate that a reduction in the histocompatibility antigens of the leukemic leukocyte occurs contemporaneously with the appearance of tumor-specific antigens, and both phenomena are most likely related to neoplastic transformation. The following hypotheses are discussed as possible explanations of these phenomena: the possibility of true antigen deletion; the spreading out of membrane antigenic receptors as a consequence of increased cellular volume; the appearance of the TL antigen in the leukemic cells causing a partial loss of H-2 antigens.
Collapse
|
5
|
Abstract
Using a short-term culture technique it has been possible to cultivate mouse peripheral lymphocytes from various strains for as long as 96 hours. With this technique a study was made to determine whether mouse peripheral lymphocytes could be stimulated by PHA « in vitro ». Swiss (non-inbred) and CBA (inbred) mice of both sexes, 3–12 months old, were used throughout this study. Blood was obtained from the retro-orbital sinus of ether-anesthetized animals, collected in heparinized tubes and pooled according to sex and strain. Leukocyte separation was effected by sedimentation in Plasmagel for 15'. The supernatant was transferred to an equal volume of Hanks Balanced Salt Solution (HBSS) and spun down for 20’ at 250–300 × g. The resulting cell sediment was washed twice with HBSS and resuspended in 2 ml Trowell T8 medium which contained 30 - 40 % calf serum which had been pre-heated for 30’ in a 56 °C water bath. After a differential cell count, the cell suspension was further diluted to achieve 106 lymphocytes/ml. Red blood cell contamination corresponded to 30 rbc/1 wbc with granulocyte population varying 10–40 %. 3 × 106 lymphocytes were placed in glass culture tubes prepared in advance by adding 2 ml of 1.5 % agar in HBSS and allowing it to solidify in the bottom of upright tubes. 0.1 ml PHA-M was added to each tube and the cultures were kept upright in a controlled gas phase incubator for 24–96 hours at 37 °C. At the end of the incubation period, the cultures were transferred to centrifuge tubes and spun down for 10’ as above and smears were made directly from the dense sediment after the supernatant was discarded. These smears were fixed, stained and read for the presence of transformed cells scoring at least 1000 cells/culture. Some cultures received 3 μg colchicine 2–6 hours before harvesting and chromosome preparations were made. Mitotic indexes were estimated by scoring 1000 cells/culture. Swiss cultures were also employed for radioautography by adding 3H-thymidine 6 hours before harvesting. Cells were then washed once in HBSS, subjected to short hypotonic treatment, rapidly fixed, pipetted on to slides and allowed to dry. Slides were coated with Kodak NTB2 emulsion, exposed for 9 days, processed and stained through the film and read for labelled cells scoring 500 cells/slide. Microscopic examination revealed a prompt Mastoid transformation of the small lymphocytes which presented a deeply basophilic cytoplasm surrounding a large nucleus with reticular chromatin and one or more prominent nucleoli. Quantitation of the blastoid response at 24-hour intervals throughout the 96 hours of culture disclosed significant blast formation within the first 24 hours for both mouse strains. Differences in transformation between the 2 strains were statistically significant at 24 and 48 hours. 3H-thymidine uptake paralleled blastogenesis by increasing progressively. Differences in uptake between PHA cultures and corresponding controls were found to be statistically significant for all except the 96 - hour cultures. The results obtained suggest that mouse peripheral lymphocytes will respond to PHA stimulation provided culture conditions are adequate. There was clear evidence of stimulation by PHA in both morphology and radioautography studies. However, the day-to-day variation in values of transformation and 3H-thymidine uptake necessitate further studies to improve culture conditions. Higher variability in Swiss (non-inbred) cultures indicates that cellular factors may also influence response « in vitro ». It is concluded that mouse peripheral lymphocytes react « in vitro » to PHA in much the same way as human and other mammalian lymphocytes.
Collapse
|
6
|
Mariotto S, Ferrari S, Sorio M, Benedetti F, Tridente G, Cavallaro T, Gajofatto A, Monaco S. Brentuximab vedotin: axonal microtubule's Apollyon. Blood Cancer J 2015; 5:e343. [PMID: 26314985 DOI: 10.1038/bcj.2015.72] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Affiliation(s)
- S Mariotto
- Department of Neurological and Movement Sciences, University of Verona, Verona, Italy
| | - S Ferrari
- Department of Neurological and Movement Sciences, University of Verona, Verona, Italy
| | - M Sorio
- Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
| | - F Benedetti
- Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
| | - G Tridente
- School of Medicine, University of Verona, Verona, Italy
| | - T Cavallaro
- Department of Neurological and Movement Sciences, University of Verona, Verona, Italy
| | - A Gajofatto
- Department of Neurological and Movement Sciences, University of Verona, Verona, Italy
| | - S Monaco
- Department of Neurological and Movement Sciences, University of Verona, Verona, Italy
| |
Collapse
|
7
|
Gerosa MA, Rosenblum ML, Stevanoni G, Nicolato A, Longatti P, Bricolo A, Tridente G. Immunocytochemical characterization of long-term medulloblastoma cultures: preliminary report. Prog Exp Tumor Res 2015; 30:21-30. [PMID: 3306796 DOI: 10.1159/000413659] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
8
|
Chieco-Bianchi L, Collavo D, Pennelli N, Tridente G. Immunological and genetic factors in murine virus-induced leukemia. Bibl Haematol 2015:234-9. [PMID: 5538520 DOI: 10.1159/000391712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
9
|
Micheletti F, Moretti U, Tridente G, Zanoni G. Consultancy and surveillance of post-immunisation adverse events in the Veneto region of Italy for 1992-2008. Human Vaccines 2014; 7 Suppl:234-9. [DOI: 10.4161/hv.7.0.14613] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
10
|
Veneri D, Franchini M, Vella A, Tridente G, Semenzato G, Pizzolo G, Ortolani R. Changes of human B and B-1a peripheral blood lymphocytes with age. Hematology 2013; 12:337-41. [PMID: 17654062 DOI: 10.1080/10245330701255270] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Abstract
In 2057 consecutive subjects admitted to the Department of Pathology, Section of Immunology of the Verona University Hospital, CD19+ and CD5/CD19 double positive cells were determined to assess the behaviour of total peripheral B-lymphocytes and B-1a (CD5+) compartments in humans during aging. We show that the absolute number of total B lymphocytes increases about three-fold from the baseline conditions in the first year of life and progressively decreases until adult age. A slower decrease was detected from the adult age onwards. A similar behaviour has been observed within the B-1a subset of B-lymphocytes, although the decrease after the adult age seems more pronounced. Possible physiological explanations and/or implications for the disease states are taken into account.
Collapse
Affiliation(s)
- Dino Veneri
- Section of Hematology, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy.
| | | | | | | | | | | | | |
Collapse
|
11
|
Abstract
Alemtuzumab (Campath®, MabCampath®, Genzyme) is an IgG1k anti-CD52 humanized monoclonal antibody (mAb) that was first licensed in March 2001 by FDA. EMEA granted its approval in July 2001 and Health Canada in November 2005. The initial indication was limited to B-CLL previously treated and resistant to alkylating agents. Starting from 2007, alemtuzumab was approved also as first-line therapy of B-CLL. So far, it has been experienced in over 60 countries.
Collapse
|
12
|
Sartoris S, Mazzocco M, Tinelli M, Martini M, Mosna F, Lisi V, Indraccolo S, Moserle L, Cestari T, Riviera AP, Bifari F, Tridente G, Pizzolo G, Krampera M. Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model. Stem Cells Dev 2010; 20:709-19. [PMID: 20695752 DOI: 10.1089/scd.2010.0095] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Bone marrow mesenchymal stromal cells (BM-MSCs) may survive and proliferate in the presence of cycling neoplastic cells. Exogenously administered MSCs are actively incorporated in the tumor as stromal fibroblasts, thus competing with the local mesenchymal cell precursors. For this reason, MSCs have been suggested as a suitable carrier for gene therapy strategies, as they can be genetically engineered with genes encoding for biologically active molecules that can inhibit tumor cell proliferation and enhance the antitumor immune response. We used BM-MSCs engineered with the murine interferon-alpha (IFN-α) gene (BM-MSCs/IFN-α) to assess in a mouse plasmacytoma model the efficacy of this approach toward neoplastic plasma cells. We found that IFN-α can be efficiently produced and delivered inside the tumor microenvironment. Subcutaneous multiple administration of BM-MSCs/IFN-α significantly hampered the tumor growth in vivo and prolonged the overall survival of mice. The antitumor effect was associated with enhanced apoptosis of tumor cells, reduction in microvessel density, and ischemic necrosis. By contrast, intravenous administration of BM-MSCs/IFN-α did not significantly modify the survival of mice, mainly as a consequence of an excessive entrapment of injected cells in the pulmonary vessels. In conclusion, BM-MSCs/IFN-α are effective in inhibiting neoplastic plasma cell growth; however, systemic administration of engineered MSCs needs to be improved to make this approach potentially suitable for the treatment of multiple myeloma.
Collapse
Affiliation(s)
- Silvia Sartoris
- Department of Pathology and Diagnostics, University of Verona, Verona, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Giannone F, Malpeli G, Lisi V, Grasso S, Shukla P, Ramarli D, Sartoris S, Monsurró V, Krampera M, Amato E, Tridente G, Colombatti M, Parenti M, Innamorati G. The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis. J Mol Endocrinol 2010; 44:259-69. [PMID: 20150327 DOI: 10.1677/jme-09-0134] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Heterotrimeric G proteins transduce the signals of the largest family of membrane receptors (G protein-coupled receptors, GPCRs) hence triggering the activation of a wide variety of physiological responses. G15 is a G protein characterized by a number of functional peculiarities that make its signaling exceptional: 1) it can couple a variety of Gs-, Gi/o-, and Gq-linked receptors to phospholipase C activation; 2) relatively to other G proteins, it is poorly affected by beta-arrestin-dependent desensitization, the general mechanism that regulates GPCR function and 3) at the protein level, its expression is only detected in highly specific cell types (hematopoietic and epithelial cells). G15 alpha-subunit displays unique structural and biochemical properties, and is phylogenetically the most recent and divergent component of the Galphaq/11 subfamily. All these aspects shed a mysterious light on G15 biological role, which remains substantially elusive. Thus, far, G15 signaling has been analyzed in the context of hematopoiesis. Here, we highlight observations supporting the view that G15 functions may extend further beyond the immune system. In addition, we describe puzzling aspects of G15 signaling that offer a novel perspective in the understanding of its physiological role.
Collapse
Affiliation(s)
- Flavia Giannone
- Department of Experimental Medicine, University of Milano-Bicocca, Monza 20052, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Ortolani R, Bellavite P, Paiola F, Martini M, Marchesini M, Veneri D, Franchini M, Chirumbolo S, Tridente G, Vella A. A comparative method for processing immunological parameters: developing an "Immunogram". Blood Transfus 2010; 8:118-125. [PMID: 20383306 PMCID: PMC2851216 DOI: 10.2450/2009.0096-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 03/26/2009] [Accepted: 06/25/2009] [Indexed: 05/29/2023]
Abstract
BACKGROUND The immune system is a network of numerous cells that communicate both directly and indirectly with each other. The system is very sensitive to antigenic stimuli, which are memorised, and is closely connected with the endocrine and nervous systems. Therefore, in order to study the immune system correctly, it must be considered in all its complexity by analysing its components with multiparametric tools that take its dynamic characteristic into account. METHODS We analysed lymphocyte subpopulations by using monoclonal antibodies with six different fluorochromes; the monoclonal panel employed included CD45, CD3, CD4, CD8, CD16, CD56, CD57, CD19, CD23, CD27, CD5, and HLA-DR. This panel has enabled us to measure many lymphocyte subsets in different states and with different functions: helper, suppressor, activated, effector, naïve, memory, and regulatory. A database was created to collect the values of immunological parameters of approximately 8,000 subjects who have undergone testing since 2000. When the distributions of the values for these parameters were compared with the medians of reference values published in the literature, we found that most of the values from the subjects included in the database were close to the medians in the literature. To process the data we used a comparative method that calculates the percentile rank of the values of a subject by comparing them with the values for others subjects of the same age. RESULTS From this data processing we obtained a set of percentile ranks that represent the positions of the various parameters with regard to the data for other age-matched subjects included in the database. These positions, relative to both the absolute values and percentages, are plotted in a graph. We have called the final plot, which can be likened to that subject's immunological fingerprint, an "Immunogram". In order to perform the necessary calculations automatically, we developed dedicated software (Immunogramma) which provides at least two different "pictures" for each subject: the first is based on a comparison of the individual's data with those from all age-related subjects, while the second provides a comparison with only age and disease-related subjects. In addition, we can superimpose two fingerprints from the same subject, calculated at different times, in order to produce a dynamic picture, for instance before and after treatment. Finally, with the aim of interpreting the clinical and diagnostic meaning of a set of positions for the values of the measured parameters, we can also search the database to determine whether it contains other subjects who have a similar pattern for some selected immune parameters. CONCLUSIONS This method helps to study and follow-up immune parameters over time. The software enables automation of the process and data sharing with other departments and laboratories, so the database can grow rapidly, thus expanding its informational capacity.
Collapse
Affiliation(s)
- Riccardo Ortolani
- Sezione di Immunologia Clinica, Dipartimento di Patologia Generale, Azienda Ospedaliero-Universitaria di Verona, Verona, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Martini M, Testi MG, Pasetto M, Picchio MC, Innamorati G, Mazzocco M, Ugel S, Cingarlini S, Bronte V, Zanovello P, Krampera M, Mosna F, Cestari T, Riviera AP, Brutti N, Barbieri O, Matera L, Tridente G, Colombatti M, Sartoris S. IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer. Vaccine 2010; 28:3548-57. [PMID: 20304037 DOI: 10.1016/j.vaccine.2010.03.007] [Citation(s) in RCA: 85] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2010] [Revised: 02/22/2010] [Accepted: 03/05/2010] [Indexed: 12/31/2022]
Abstract
De novo expression of B7-1 impaired tumorigenicity of TRAMP-C2 mouse prostate adenocarcinoma (TRAMP-C2/B7), but it did not elicit a protective response against TRAMP-C2 parental tumor, unless after in vitro treatment with IFN-gamma. TRAMP-C2 cells secrete TGF-beta and show low MHC-I expression. Treatment with IFN-gamma increased MHC-I expression by induction of some APM components and antagonizing the immunosuppressant activity of TGF-beta. Thus, immunization with TRAMP-C2/B7 conferred protection against TRAMP-C2-derived tumors in function of the IFN-gamma-mediated fine-tuned modulation of either APM expression or TGF-beta signaling. To explore possible clinical translation, we delivered IFN-gamma to TRAMP-C2 tumor site by means of genetically engineered MSCs secreting IFN-gamma.
Collapse
Affiliation(s)
- Matteo Martini
- Department of Pathology and Diagnostics, Immunology Section, University of Verona, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Zanoni G, Berra P, Lucchi I, Ferro A, O’Flanagan D, Levy-Bruhl D, Salmaso S, Tridente G. Vaccine adverse event monitoring systems across the European Union countries: Time for unifying efforts☆. Vaccine 2009; 27:3376-84. [DOI: 10.1016/j.vaccine.2009.01.059] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
17
|
Innamorati G, Giannone F, Guzzi F, Rovati GE, Accomazzo MR, Chini B, Bianchi E, Schiaffino MV, Tridente G, Parenti M. Heterotrimeric G proteins demonstrate differential sensitivity to beta-arrestin dependent desensitization. Cell Signal 2009; 21:1135-42. [PMID: 19275934 DOI: 10.1016/j.cellsig.2009.03.002] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2008] [Revised: 02/19/2009] [Accepted: 03/02/2009] [Indexed: 11/15/2022]
Abstract
G15 is a heterotrimeric G protein of the Gq/11 family. In this study, we describe its exceptional poor sensitivity to the general regulatory mechanism of G protein-coupled receptor (GPCR) desensitization. Enhancing beta2 adrenergic receptor desensitization by arrestin overexpression, did not affect signalling to G15. Similarly, increased levels of arrestin did not affect G15 signalling triggered by the activation of V2 vasopressin and delta opioid receptors. Furthermore, co-immunoprecipitation experiments showed that G15 alpha subunit (as opposed to Galphaq and Galphas) is recruited to a V2 vasopressin receptor mutant that is constitutively desensitized by beta-arrestin. Interestingly, co-expression of Galpha15 partially rescued cell surface localization and signalling capabilities of the same mutant receptor and reduced beta2 adrenergic receptor internalization. Taken together, these findings provide evidence for a novel mechanism whereby GPCR desensitization can be bypassed and G15 can support sustained signalling in cells chronically exposed to hormones or neurotransmitters.
Collapse
Affiliation(s)
- Giulio Innamorati
- Department of Pathology, Immunology Unit, University of Verona, c/o Policlinico G.B. Rossi, Piazzale L.A. Scuro 10, Verona, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Colombatti M, Grasso S, Porzia A, Fracasso G, Scupoli MT, Cingarlini S, Poffe O, Naim HY, Heine M, Tridente G, Mainiero F, Ramarli D. The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. PLoS One 2009; 4:e4608. [PMID: 19242540 PMCID: PMC2643478 DOI: 10.1371/journal.pone.0004608] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2008] [Accepted: 01/17/2009] [Indexed: 12/23/2022] Open
Abstract
The interleukin-6 (IL-6) and the chemokine CCL5 are implicated in the development and progression of several forms of tumours including that of the prostate. The expression of the prostate specific membrane antigen (PSMA) is augmented in high-grade and metastatic tumors. Observations of the clinical behaviour of prostate tumors suggest that the increased secretion of IL-6 and CCL5 and the higher expression of PSMA may be correlated. We hypothesized that PSMA could be endowed with signalling properties and that its stimulation might impact on the regulation of the gene expression of IL-6 and CCL5. We herein demonstrate that the cross-linking of cell surface PSMA with specific antibodies activates the small GTPases RAS and RAC1 and the MAPKs p38 and ERK1/2 in prostate carcinoma LNCaP cells. As downstream effects of the PSMA-fostered RAS-RAC1-MAPK pathway activation we observed a strong induction of NF-κB activation associated with an increased expression of IL-6 and CCL5 genes. Pharmacological blockade with specific inhibitors revealed that both p38 and ERK1/2 participate in the phenomenon, although a major role exerted by p38 was evident. Finally we demonstrate that IL-6 and CCL5 enhanced the proliferative potential of LNCaP cells synergistically and in a dose-dependent manner and that CCL5 functioned by receptor-mediated activation of the STAT5-Cyclin D1 pro-proliferative pathway. The novel functions attributable to PSMA which are described in the present report may have profound influence on the survival and proliferation of prostate tumor cells, accounting for the observation that PSMA overexpression in prostate cancer patients is related to a worse prognosis.
Collapse
Affiliation(s)
| | - Silvia Grasso
- Department of Pathology, University of Verona, Verona, Italy
| | - Alessandra Porzia
- Department of Experimental Medicine, Institute Pasteur-Fondazione Cenci Bolognetti, University of Rome “La Sapienza”, Rome, Italy
| | - Giulio Fracasso
- Department of Pathology, University of Verona, Verona, Italy
| | - Maria Teresa Scupoli
- Interdepartmental Laboratory for Medical Research (LURM), University of Verona, Verona, Italy
| | - Sara Cingarlini
- Department of Pathology, University of Verona, Verona, Italy
| | - Ornella Poffe
- Department of Pathology, University of Verona, Verona, Italy
| | - Hassan Y. Naim
- Department of Physiological Chemistry, School of Veterinary Medicine, Hannover, Germany
| | - Martin Heine
- Department of Physiological Chemistry, School of Veterinary Medicine, Hannover, Germany
| | - Giuseppe Tridente
- Department of Pathology, University of Verona, Verona, Italy
- Clinical Immunology, Giovanni Battista Rossi Hospital, Verona, Italy
| | - Fabrizio Mainiero
- Department of Experimental Medicine, Institute Pasteur-Fondazione Cenci Bolognetti, University of Rome “La Sapienza”, Rome, Italy
| | - Dunia Ramarli
- Clinical Immunology, Giovanni Battista Rossi Hospital, Verona, Italy
- * E-mail:
| |
Collapse
|
19
|
Gerosa MA, Rosenblum ML, Stevanoni G, Tommasi M, Corte VD, Licata C, Bricolo A, Tridente G. In vitro analysis of BCNU-sensitivity in human malignant gliomas. Acta Neurol Scand 2009. [DOI: 10.1111/j.1600-0404.1985.tb00893.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
20
|
Canuti M, Bianchi S, Zappa A, Koncan R, Pariani E, Cornaglia G, Tanzi E, Zanetti A, Tridente G, Amendola A. O.2.3 Viability of vaccine strains in a pharmaceutical dump. J Clin Virol 2009. [DOI: 10.1016/s1386-6532(08)70029-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
21
|
Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, O Flanagan D. National seasonal influenza vaccination survey in Europe, 2008. ACTA ACUST UNITED AC 2008; 13. [PMID: 18947524 DOI: 10.2807/ese.13.43.19017-en] [Citation(s) in RCA: 75] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
A cross-sectional survey was undertaken with the European Union (EU) Member States and Norway and Iceland to describe seasonal influenza immunisation in the 2006-7 season, in particular to identify country-specific recommendations for risk groups, obtain vaccine uptake information and allow comparison with global recommendations. A standardised questionnaire was completed electronically by each country's project gatekeeper. Of the 29 countries surveyed, 28 recommended seasonal influenza vaccination for older age groups (22 for those aged > 65 years), and in one country vaccine was recommended for all age groups. All countries recommended vaccinating patients with chronic pulmonary and cardiovascular diseases and most countries advised to immunise patients with haematologic or metabolic disorders (n=28), immunologic disorders (n=27) and renal disease (n=27), as well as residents of long-term care facilities (n=24). Most countries recommended vaccination for staff in hospitals (n=25), long-term care facilities (n=25) and outpatient clinics (n=23), and one-third had such recommendations for workers in essential (n=10), military (n=10) and veterinary services (n=10) and poultry industry (n=13). Eight countries recommended vaccine for pregnant women; and five advised to vaccinate children (with age limits ranging from 6 months to 5 years). Twenty countries measured influenza vaccine uptake among those aged > 65 years (range 1.8%-82.1%), seven reported uptake in healthcare workers (range 14%-48%) and seven assessed coverage in persons with underlying medical conditions (range 27.6%-75.2%). The data provided by this study can assist EU states to assess and compare their influenza vaccination programme performance with other countries. The information provides a comprehensive overview of policies and programmes and their outcomes and can be used to inform joint discussions on how the national policies in the EU might be standardised in the future to achieve optimal coverage. Annual surveys could be used to monitor changes in these national policies.
Collapse
Affiliation(s)
- J Mereckiene
- Health Protection Surveillance Centre, Dublin, Ireland.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Chirumbolo S, Vella A, Ortolani R, De Gironcoli M, Solero P, Tridente G, Bellavite P. Differential response of human basophil activation markers: a multi-parameter flow cytometry approach. Clin Mol Allergy 2008; 6:12. [PMID: 18925959 PMCID: PMC2584049 DOI: 10.1186/1476-7961-6-12] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2008] [Accepted: 10/16/2008] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND Basophils are circulating cells involved in hypersensitivity reactions and allergy but many aspects of their activation, including the sensitivity to external triggering factors and the molecular aspects of cell responses, are still to be focused. In this context, polychromatic flow cytometry (PFC) is a proper tool to investigate basophil function, as it allows to distinguish the expression of several membrane markers upon activation in multiple experimental conditions. METHODS Cell suspensions were prepared from leukocyte buffy coat of K2-EDTA anticoagulated blood specimens; about 1500-2500 cellular events for each tested sample, gated in the lymphocyte CD45dim area and then electronically purified as HLADRnon expressing/CD123bright, were identified as basophilic cells. Basophil activation with fMLP, anti-IgE and calcium ionophore A23187 was evaluated by studying up-regulation of the indicated membrane markers with a two-laser six-color PFC protocol. RESULTS Following stimulation, CD63, CD13, CD45 and the ectoenzyme CD203c up-regulated their membrane expression, while CD69 did not; CD63 expression occurred immediately (within 60 sec) but only in a minority of basophils, even at optimal agonist doses (in 33% and 14% of basophils, following fMLP and anti-IgE stimulation respectively). CD203c up-regulation occurred in the whole basophil population, even in CD63non expressing cells. Dose-dependence curves revealed CD203c as a more sensitive marker than CD63, in response to fMLP but not in response to anti-IgE and to calcium ionophore. CONCLUSION Use of polychromatic flow cytometry allowed efficient basophil electronic purification and identification of different behaviors of the major activation markers. The simultaneous use of two markers of activation and careful choice of activator are essential steps for reliable assessment of human basophil functions.
Collapse
Affiliation(s)
| | - Antonio Vella
- Department of Pathology-Section of Immunology-University of Verona, Italy
| | - Riccardo Ortolani
- Department of Pathology-Section of Immunology-University of Verona, Italy
| | - Marzia De Gironcoli
- Immunotransfusion Service-University Hospital Policlinico GB Rossi, Verona, Italy
| | - Pietro Solero
- Department of Morphological and Biomedical Science-University of Verona, Italy
| | - Giuseppe Tridente
- Department of Pathology-Section of Immunology-University of Verona, Italy
| | - Paolo Bellavite
- Department of Morphological and Biomedical Science-University of Verona, Italy
| |
Collapse
|
23
|
Chignola R, Schenetti A, Andrighetto G, Chiesa E, Foroni R, Sartoris S, Tridente G, Liberati D. Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. Cell Prolif 2008; 33:219-29. [PMID: 11041203 PMCID: PMC6495301 DOI: 10.1046/j.1365-2184.2000.00174.x] [Citation(s) in RCA: 70] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The growth dynamics of multicell tumour spheroids (MTS) were analysed by means of mathematical techniques derived from signal processing theory. Volume vs. time trajectories of individual spheroids were fitted with the Gompertz growth equation and the residuals (i.e. experimental volume determinations minus calculated values by fitting) were analysed by fast fourier transform and power spectrum. Residuals were not randomly distributed around calculated growth trajectories demonstrating that the Gompertz model partially approximates the growth kinetics of three-dimensional tumour cell aggregates. Power spectra decreased with increasing frequency following a 1/f(delta) power-law. Our findings suggest the existence of a source of 'internal' variability driving the time-evolution of MTS growth. Based on these observations, a new stochastic Gompertzian-like mathematical model was developed which allowed us to forecast the growth of MTS. In this model, white noise is additively superimposed to the trend described by the Gompertz growth equation and integrated to mimic the observed intrinsic variability of MTS growth. A correlation was found between the intensity of the added noise and the particular upper limit of volume size reached by each spheroid within two MTS populations obtained with two different cell lines. The dynamic forces generating the growth variability of three-dimensional tumour cell aggregates also determine the fate of spheroid growth with a strong predictive significance. These findings suggest a new approach to measure tumour growth potential.
Collapse
Affiliation(s)
- R Chignola
- Department of Pathology, University of Verona, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Mereckiene J, Cotter S, Weber JT, Nicoll A, Lévy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, on behalf of the VENICE gatekeepers group C. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill 2008; 13. [DOI: 10.2807/ese.13.41.19001-en] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
In May 2003, the 56th World Health Assembly (WHA) recommended influenza vaccination for all people at high risk defined as the elderly and persons with underlying diseases [1]. The WHA countries, including all European Union (EU) Member States, also committed to the goal of attaining vaccination coverage of the elderly population of at least 50% by 2006 and 75% by 2010 and to having mechanisms for monitoring the uptake [1]. To date there has been no published survey on how successful European countries have been in implementing this WHA resolution.
Collapse
Affiliation(s)
- J Mereckiene
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Health Protection Surveillance Centre, Dublin, Ireland
| | - S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | - J T Weber
- Centers for Disease Control and Prevention (CDC), Atlanta, United States
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - A Nicoll
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - D Lévy-Bruhl
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Institut de Veille Sanitare, Saint-Maurice, France
| | - A Ferro
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Department of Prevention, Public Health Unit nr 17, Veneto Region, Italy
| | - G Tridente
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- The Green Channel Regional Reference Centre for Vaccination, Veneto, Italy
| | - G Zanoni
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- The Green Channel Regional Reference Centre for Vaccination, Veneto, Italy
| | - P Berra
- The Green Channel Regional Reference Centre for Vaccination, Veneto, Italy
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | - S Salmaso
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Istituto Superiore di Sanitá, Rome, Italy
| | - D O'Flanagan
- Health Protection Surveillance Centre, Dublin, Ireland
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | | |
Collapse
|
25
|
Sansoni P, Tridente G, Valente G, Butturini U. RESPONSIVENESS TO SEPHAROSE PROTEIN A FROM Staphylococcus aureus OF LYMPHOID CELLS IN A CASE OF PROLYMPHOCYTIC LEUKAEMIA. Br J Haematol 2008. [DOI: 10.1111/j.1365-2141.1983.00317.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
Amendola A, Bianchi S, Canuti M, Zappa A, Zanoni G, Koncan R, Tanzi E, Cornaglia G, Remo Zanetti A, Tridente G. Viable Newcastle disease vaccine strains in a pharmaceutical dump. Emerg Infect Dis 2008; 13:1901-3. [PMID: 18258042 PMCID: PMC2876766 DOI: 10.3201/eid1312.070715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
To assess the viability of discarded and buried vaccine strains, we examined vaccines that had been buried for >20 years in an industrial waste dump in the city of Milan, Italy. Viability results showed potential biological risk associated with uncontrolled burial of pharmaceutical industry waste, including some live vaccines.
Collapse
|
27
|
Boschiero L, Nacchia F, Fior F, Cordiano C, Tridente G, Bellisola G. Specific alloantigen self-control by regulatory T cells in organ transplantation: a review. Transplant Proc 2007; 39:2013-7. [PMID: 17692679 DOI: 10.1016/j.transproceed.2007.05.043] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Multidrug immunosuppressive protocols have increased short-term patient and graft survival rates from 50% to 90% in the past two decades. Unfortunately, chronic graft rejection still remains the main cause of long-term failure and patients must undergo lifelong immunosuppression. The severe side effects such as life-threatening infections, secondary malignancies, and cardiovascular dysfunction all together include roughly 50% of deaths among kidney transplant patients with functioning grafts. Therefore, it should be of crucial importance to reduce immunosuppression and seek induction of specific tolerance to donor alloantigens. Several investigations have suggested that the acquisition of tolerance to self and/or foreign antigens is dependent on the number and function of naturally occurring and acquired regulatory T cells, which can control all aggressive T cells. The regulatory T cells together with their receptors, costimulatory molecules, cytokines, chemokines, and growth factors all contribute to maintain an equilibrium between aggressive and suppressive effector immune responses. As a consequence of increased knowledge, new immunosuppressive approaches based on either alloantigen-specific regulatory T-cell expansion in vivo or in vitro have been proposed to achieve donor-specific transplantation tolerance in kidney allograft recipients. This contribution attempted to summarize knowledge about regulatory T cells and developing methods to induce specific tolerance in kidney transplantation.
Collapse
Affiliation(s)
- L Boschiero
- Renal Transplant Unit, Azienda Ospedaliera di Verona, Verona, Italy
| | | | | | | | | | | |
Collapse
|
28
|
Krampera M, Sartoris S, Liotta F, Pasini A, Angeli R, Cosmi L, Andreini A, Mosna F, Bonetti B, Rebellato E, Testi MG, Frosali F, Pizzolo G, Tridente G, Maggi E, Romagnani S, Annunziato F. Immune Regulation by Mesenchymal Stem Cells Derived from Adult Spleen and Thymus. Stem Cells Dev 2007; 16:797-810. [DOI: 10.1089/scd.2007.0024] [Citation(s) in RCA: 98] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Affiliation(s)
- Mauro Krampera
- Department of Clinical and Experimental Medicine, Section of Haematology, University of Verona, Italy
| | - Silvia Sartoris
- Department of Pathology, Section of Immunology, University of Verona, Italy
| | | | - Annalisa Pasini
- Department of Clinical and Experimental Medicine, Section of Haematology, University of Verona, Italy
| | - Roberta Angeli
- Excellence Center of the University of Florence DENOthe, Italy
| | - Lorenzo Cosmi
- Excellence Center of the University of Florence DENOthe, Italy
| | - Angelo Andreini
- Department of Clinical and Experimental Medicine, Section of Haematology, University of Verona, Italy
| | - Federico Mosna
- Department of Clinical and Experimental Medicine, Section of Haematology, University of Verona, Italy
| | - Bruno Bonetti
- Department of Neurological Sciences and Vision, Section of Neurology, University of Verona, Italy
| | | | - Maria Grazia Testi
- Department of Pathology, Section of Immunology, University of Verona, Italy
| | | | - Giovanni Pizzolo
- Department of Clinical and Experimental Medicine, Section of Haematology, University of Verona, Italy
| | - Giuseppe Tridente
- Department of Pathology, Section of Immunology, University of Verona, Italy
| | - Enrico Maggi
- Excellence Center of the University of Florence DENOthe, Italy
| | | | | |
Collapse
|
29
|
Zanusso G, Polo A, Farinazzo A, Nonno R, Cardone F, Di Bari M, Ferrari S, Principe S, Gelati M, Fasoli E, Fiorini M, Prelli F, Frangione B, Tridente G, Bentivoglio M, Giorgi A, Schininà ME, Maras B, Agrimi U, Rizzuto N, Pocchiari M, Monaco S. Novel Prion Protein Conformation and Glycotype in Creutzfeldt-Jakob Disease. ACTA ACUST UNITED AC 2007; 64:595-9. [PMID: 17420324 DOI: 10.1001/archneur.64.4.595] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
OBJECTIVE To describe a novel molecular and pathological phenotype of Creutzfeldt-Jakob disease. Patient A 69-year-old woman with behavioral and personality changes followed by rapidly evolving dementia. RESULTS Postmortem examination of the brain showed intracellular prion protein deposition and axonal swellings filled with amyloid fibrils. Biochemical analysis of the pathological prion protein disclosed a previously unrecognized PrP(Sc) tertiary structure lacking diglycosylated species. Genetic analysis revealed a wild-type prion protein gene. The prion agent responsible for this atypical phenotype was successfully passaged to bank voles. CONCLUSION To our knowledge, our results define a new human prion disorder characterized by intracellular accumulation of a novel type of pathological prion protein.
Collapse
|
30
|
Amendola A, Bianchi S, Canuti M, Koncan R, Zanetti A, Tridente G, Cornaglia G. P1569 Strategies for containment of biological risk in reclaiming a large urban area used as a waste pit by a serum and vaccine factory. Int J Antimicrob Agents 2007. [DOI: 10.1016/s0924-8579(07)71408-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
Pastore Celentano L, Lopalco PL, O'Flanagan D, Levy-Bruhl D, Ferro A, Tridente G, Appelgren E, Salmaso S. Venice: Europe's new network for vaccination. Euro Surveill 2007; 12:E070118.3. [PMID: 17370937 DOI: 10.2807/esw.12.03.03116-en] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/14/2023] Open
Abstract
Vaccination is an extremely effective tool in reducing the burden of infectious diseases. There are many vaccine products currently available in Europe. Vaccines developed recently have been introduced according to common European Union (EU)-wide regulatory procedures since 2003, which implies that they are licensed for common indications and population groups across the EU.
Collapse
Affiliation(s)
- L Pastore Celentano
- Centro Nazionale Epidemiologia, Sorveglianza e Promozione della Salute (CNESP), Istituto Superiore di Sanità, Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, Beri R, Dolcino M, Valletta E, Corrocher R, Puccetti A. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 2006; 3:e358. [PMID: 16984219 PMCID: PMC1569884 DOI: 10.1371/journal.pmed.0030358] [Citation(s) in RCA: 140] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2005] [Accepted: 06/29/2006] [Indexed: 01/13/2023] Open
Abstract
BACKGROUND Celiac disease is a small intestine inflammatory disorder with multiple organ involvement, sustained by an inappropriate immune response to dietary gluten. Anti-transglutaminase antibodies are a typical serological marker in patients with active disease, and may disappear during a gluten-free diet treatment. Involvement of infectious agents and innate immunity has been suggested but never proven. Molecular mimicry is one of the mechanisms that links infection and autoimmunity. METHODS AND FINDINGS In our attempt to clarify the pathogenesis of celiac disease, we screened a random peptide library with pooled sera of patients affected by active disease after a pre-screening with the sera of the same patients on a gluten-free diet. We identified a peptide recognized by serum immunoglobulins of patients with active disease, but not by those of patients on a gluten-free diet. This peptide shares homology with the rotavirus major neutralizing protein VP-7 and with the self-antigens tissue transglutaminase, human heat shock protein 60, desmoglein 1, and Toll-like receptor 4. We show that antibodies against the peptide affinity-purified from the sera of patients with active disease recognize the viral product and self-antigens in ELISA and Western blot. These antibodies were able to induce increased epithelial cell permeability evaluated by transepithelial flux of [(3)H] mannitol in the T84 human intestinal epithelial cell line. Finally, the purified antibodies induced monocyte activation upon binding Toll-like receptor 4, evaluated both by surface expression of activation markers and by production of pro-inflammatory cytokines. CONCLUSIONS Our findings show that in active celiac disease, a subset of anti-transglutaminase IgA antibodies recognize the viral protein VP-7, suggesting a possible involvement of rotavirus infection in the pathogenesis of the disease, through a mechanism of molecular mimicry. Moreover, such antibodies recognize self-antigens and are functionally active, able to increase intestinal permeability and induce monocyte activation. We therefore provide evidence for the involvement of innate immunity in the pathogenesis of celiac disease through a previously unknown mechanism of engagement of Toll-like receptor 4.
Collapse
Affiliation(s)
- Giovanna Zanoni
- Section of Immunology, Department of Pathology, University of Verona, Verona, Italy
| | - Riccardo Navone
- Section of Internal Medicine, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
| | - Claudio Lunardi
- Section of Internal Medicine, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
| | - Giuseppe Tridente
- Section of Immunology, Department of Pathology, University of Verona, Verona, Italy
| | - Caterina Bason
- Section of Internal Medicine, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
| | - Simona Sivori
- Section of Histology, Department of Experimental Medicine, University of Genova, Genova, Italy
| | - Ruggero Beri
- Section of Internal Medicine, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
| | | | - Enrico Valletta
- Department of Pediatrics, University Hospital of Verona, Verona, Italy
| | - Roberto Corrocher
- Section of Internal Medicine, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
| | - Antonio Puccetti
- Section of Histology, Department of Experimental Medicine, University of Genova, Genova, Italy
- Immunology Unit, Institute G. Gaslini, Genova, Italy
| |
Collapse
|
33
|
Bellisola G, Tridente G, Nacchia F, Fior F, Boschiero L. Monitoring of Cellular Immunity by Interferon-Gamma Enzyme-Linked Immunosorbent Spot Assay in Kidney Allograft Recipients: Preliminary Results of a Longitudinal Study. Transplant Proc 2006; 38:1014-7. [PMID: 16757248 DOI: 10.1016/j.transproceed.2006.02.142] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Several efforts have been made in past years to identify markers for patients at heightened risk of acute and chronic immune-mediated allograft rejection. The ex vivo monitoring of cellular immunity by the enzyme-linked immunosorbent spot (ELISPOT) assay has recently emerged as a primary tool in predicting short- and long-term outcomes in kidney allograft recipients. Therefore, we started the systematic application of interferon-gamma (IFN-gamma) ELISPOT assay to measure the frequency of producing IFN-gamma in recipient peripheral blood lymphocytes (PBLs) stimulated with donor lymphocytes before and 7, 14, 21, 28, and 60 days after transplantation. Preliminary results in eight kidney transplant patients indicated that the number of HLA mismatches never correlated with the number of IFN-gamma spots. The frequencies of pretransplantation IFN-gamma spots were positively and significantly correlated with the number of posttransplantation IFN-gamma spots. Clinical outcomes were better among recipients with lower frequencies than those with higher frequencies of pre- and/or posttransplantation IFN-gamma spots. The highest pre- and posttransplantation number of IFN-gamma spots was observed in a patient who developed early acute rejection. Significant increases in the number of IFN-gamma spots preceded the onset of acute rejection events and were decreased by supplemental IV steroid administration. Considering the low number of observations, these preliminary results must be considered cautiously; nevertheless, we are encouraged to extend the systematic application of serial IFN-gamma ELISPOT assay measurements in a more consistent cohort of patients.
Collapse
Affiliation(s)
- G Bellisola
- Department of Pathology, Section of Immunology, University of Verona, Italy.
| | | | | | | | | |
Collapse
|
34
|
Zipeto D, Matucci A, Ripamonti C, Scarlatti G, Rossolillo P, Turci M, Sartoris S, Tridente G, Bertazzoni U. Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes. Microbes Infect 2006; 8:1424-33. [PMID: 16702010 DOI: 10.1016/j.micinf.2006.03.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2005] [Revised: 05/12/2005] [Accepted: 05/12/2005] [Indexed: 11/21/2022]
Abstract
Human immunodeficiency virus-1 (HIV-1) infects cells by membrane fusion that is mediated by the envelope proteins gp120/gp41 and the cellular receptors CD4 and CCR5. During this process, some conserved viral epitopes are temporarily exposed and may induce a neutralizing antibody response when fixed in the fusogenic conformation. These transient structures are conserved and may be effective antigens for use in an anti-HIV-1 vaccine. In this study we tested different conditions of preparation of fusion complexes inducing neutralizing antibodies against both R5 and X4 tropic HIV-1 strains. Cell lines expressing HIV-1 gp120/gp41 and CD4-CCR5 were prepared and conditions for producing fusion complexes were tested. Complexes produced at different temperature and fixative combinations were used to immunize mice. Results indicated that (a) fusion complexes prepared at either 21 degrees C, 30 degrees C or 37 degrees C were immunogenic and induced neutralizing antibodies against both R5 and X4 HIV-1 heterologous isolates; (b) after extensive purification of antibodies there was no cytotoxic effect; (c) complexes prepared at 37 degrees C were more immunogenic and induced higher titers of neutralizing antibodies than complexes prepared at either 21 degrees C or 30 degrees C; (d) the fixative used did not affect the titer of neutralizing antibodies except for glutaraldehyde which was ineffective; (e) the neutralizing activity was retained after CD4-CCR5 antibody removal. The production of higher titers of neutralizing antibody with fusion complexes prepared at 37 degrees C, as compared to lower temperatures, may be related to the induction of antibodies against many different conformation intermediates that subsequently act synergistically at different steps in the fusion process.
Collapse
Affiliation(s)
- Donato Zipeto
- Laboratory of Molecular Virology, Department of Mother and Child, Biology and Genetics, Section of Biology and Genetics, University of Verona, Strada le Grazie n. 8, 37134 Verona, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Colombara M, Antonini V, Riviera AP, Mainiero F, Strippoli R, Merola M, Fracasso G, Poffe O, Brutti N, Tridente G, Colombatti M, Ramarli D. Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. J Immunol 2006; 175:7021-8. [PMID: 16272363 DOI: 10.4049/jimmunol.175.10.7021] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Myasthenia gravis (MG) is an autoimmune disease of neuromuscular junctions where thymus plays a pathogenetic role. Thymectomy benefits patients, and thymic hyperplasia, a lymphoid infiltration of perivascular spaces becoming site of autoantibody production, is recurrently observed. Cytokines and chemokines, produced by thymic epithelium and supporting survival and migration of T and B cells, are likely to be of great relevance in pathogenesis of thymic hyperplasia. In thymic epithelial cell (TEC) cultures derived "in vitro" from normal or hyperplastic age-matched MG thymuses, we demonstrate by gene profiling analysis that MG-TEC basally overexpress genes coding for p38 and ERK1/2 MAPKs and for components of their signaling pathways. Immunoblotting experiments confirmed that p38 and ERK1/2 proteins were overexpressed in MG-TEC and, in addition, constitutively activated. Pharmacological blockage with specific inhibitors confirmed their role in the control of IL-6 and RANTES gene expression. According to our results, IL-6 and RANTES levels were abnormally augmented in MG-TEC, either basally or upon induction by adhesion-related stimuli. The finding that IL-6 and RANTES modulate, respectively, survival and migration of peripheral lymphocytes of myasthenic patients point to MAPK transcriptional and posttranscriptional abnormalities of MG-TEC as a key step in the pathological remodelling of myasthenic thymus.
Collapse
Affiliation(s)
- Michaela Colombara
- Section of Immunology, Department of Pathology, University of Verona, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Zipeto D, Matucci A, Ripamonti C, Scarlatti G, Rossolillo P, Turci M, Sartoris S, Tridente G, Bertazzoni U. WITHDRAWN: Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes. Microbes Infect 2005. [DOI: 10.1016/j.micinf.2005.05.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
37
|
Abstract
Modern vaccinology and public health organizations need to satisfy an increased safety demand. Therefore, to improve adverse events following immunization (AEFIs) surveillance systems, some countries have established clinical evaluation centers for AEFI assessment and management of at risk individuals. In the Veneto region of Italy, the Green Channel operates through a counselling service for subjects with prior AEFI or with suspected contraindications to vaccine administration, and a surveillance system of the AEFIs reported in the region. Updated data on 753 consultations and 3023 AEFI analyses are discussed together with the opportunity to include the Green Channel model as part of an international vaccine safety network.
Collapse
Affiliation(s)
- G Zanoni
- Immunology Unit, Department of Pathology, University of Verona, Policlinico G.B. Rossi, 37134 Verona, Italy.
| | | | | | | |
Collapse
|
38
|
Matucci A, Zanusso G, Gelati M, Farinazzo A, Fiorini M, Ferrari S, Andrighetto G, Cestari T, Caramelli M, Negro A, Morbin M, Chiesa R, Monaco S, Tridente G. Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. Brain Res Bull 2005; 65:155-62. [PMID: 15763182 DOI: 10.1016/j.brainresbull.2004.12.008] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2004] [Revised: 12/24/2004] [Accepted: 12/30/2004] [Indexed: 11/29/2022]
Abstract
The availability of specific monoclonal antibodies (mAbs) recognizing the aberrant form (PrP(Sc)) of the cellular prion protein (PrP(C)) in different mammalian species is important for molecular diagnostics, PrP(Sc) typing and future immunotherapy. We obtained a panel of anti-PrP monoclonal antibodies in PrP(0/0) knock-out mice immunized with recombinant human PrP(23-231). Two mAbs, recognizing PrP epitopes in the alpha-helix 1 (mAb SA65) and alpha-helix 2 (mAb SA21) regions, immunoreacted with PrP(C) and PrP(Sc) and its proteolytic product, PrP27-30, from human, murine, bovine, caprine and ovine brains by Western blot. Remarkably, mAb SA21 recognized unglycosylated and monoglycosylated PrP with the second site occupied by glycan moieties, but not monoglycosylated PrP with the first consensus site occupied or highly glycosylated species. Immunoblots with mAb SA21 disclosed that PrP glycosylated at the second site accounted for the slower migrating form of the customary monoglycosylated PrP doublet. mAb SA65 immunolabelled all PrP glycoforms by Western blot and was highly efficient in detecting tissue PrP by immunohistochemistry in light microscopy and in immunoelectron microscopy. These novel anti-PrP mAbs provide tools to investigate the subcellular site of PrP deposition in mammalian prion diseases and may also contribute to assess the role of different PrP glycoforms in human and animal prion diseases.
Collapse
Affiliation(s)
- Andrea Matucci
- Section of Immunology, Department of Pathology, University of Verona, Policlinico G.B. Rossi, P. le L.A. Scuro 10, 37134 Verona, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Castelletti D, Fracasso G, Righetti S, Tridente G, Schnell R, Engert A, Colombatti M. A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin. Clin Exp Immunol 2004; 136:365-72. [PMID: 15086403 PMCID: PMC1809030 DOI: 10.1111/j.1365-2249.2004.02442.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Hodgkin's lymphoma patients treated with an anti-CD25 Ricin toxin A-chain (RTA)-based Immunotoxin (RFT5.dgA) develop an immune response against the toxic moiety of the immunoconjugate. The anti-RTA antibody response of 15 patients showing different clinical features and receiving different total amounts of RFT5.dgA was therefore studied in detail, considering antibody titre, IgG and IgM content, average binding efficacy and ability to inhibit in vitro the cytotoxicity of a RTA-based Immunotoxin. No correlations were found between these parameters and the clinical features of the patients or the total amount of Immunotoxin administered. However, using a peptide scan approach we have identified a continuous epitope recognized by all patients studied, located within the stretch L161-I175 of the RTA primary sequence, close to a previously identified T-cell epitope. The ability of anti-L161-I175 antibodies to recognize folded RTA and to affect the biological activity of RTA by inhibiting RTA-IT cytotoxicity in vitro revealed that they may exert an important role in IT neutralization in vivo. Discovery of RTA immunodominant epitopes which are the target of anti-RTA immune response may lead to the development of immunomodulating strategies and to more successful treatment schedules.
Collapse
Affiliation(s)
- D Castelletti
- Section of Immunology, Department of Pathology, University of Verona, Italy
| | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
Targeted toxins represent an invaluable tool offering a wide range of potential applications, both in experimental models and in the clinics. Here we will review several aspects related to the preparation and properties of carrier molecule-toxin heteroconjugates and fusion toxins.
Collapse
Affiliation(s)
- Giulio Fracasso
- Section of Immunology, Department of Pathology, University of Verona, Italy
| | | | | | | | | |
Collapse
|
41
|
Bellisola G, Fracasso G, Ippoliti R, Menestrina G, Rosén A, Soldà S, Udali S, Tomazzolli R, Tridente G, Colombatti M. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. Biochem Pharmacol 2004; 67:1721-31. [PMID: 15081871 DOI: 10.1016/j.bcp.2004.01.013] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2003] [Accepted: 01/13/2004] [Indexed: 11/20/2022]
Abstract
Intracellular activation of ricin and of the ricin A-chain (RTA) immunotoxins requires reduction of their intersubunit disulfide(s). This crucial event is likely to be catalyzed by disulfide oxidoreductases and precedes dislocation of the toxic subunit to the cytosol. We investigated the role of protein disulfide isomerase (EC 5.3.4.1, PDI), thioredoxin (Trx), and thioredoxin reductase (EC 1.8.1.9, TrxR) in the reduction of ricin and of a ricin A-chain immunotoxin by combining enzymatic assays, SDS-PAGE separation and immunoblotting. We found that, whereas PDI, Trx, and TrxR used separately were unable to directly reduce ricin and the immunotoxin, PDI and Trx in the presence of TrxR and NADPH could reduce both ricin and immunotoxin in vitro. PDI functioned only after pre-incubation with TrxR and the reductive activation of ricin was more efficient in the presence of glutathione. Similar results were obtained with microsomal membranes or crude cell extracts. Pre-incubation with the gold(I) compound auranofin, which irreversibly inactivates TrxR, resulted in a dose-dependent inhibition of ricin and immunotoxin reduction. Reductive activation of ricin and immunotoxin decreased or was abolished in microsomes depleted of TrxR and in cell extracts depleted of both PDI and Trx. Pre-incubation of U-937, Molt-3, Jurkat, and DU145 cells with auranofin significantly decreased ricin cytotoxicity with respect to mock-treated controls (P<0.05). Conversely, auranofin failed to protect cells from the toxicity of pre-reduced ricin which does not require intracellular reduction of disulfide between the two ricin subunits. We conclude that TrxR, by activating disulfide reductase activity of PDI, can ultimately lead to reduction/activation of ricin and immunotoxin in the cell.
Collapse
Affiliation(s)
- Giuseppe Bellisola
- Department of Pathology, Section of Immunology, University of Verona, Policlinico G.B. Rossi, L.go L.A. Scuro 10, I-37134 Verona, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Sartoris S, Testi MG, Stefani E, Chignola R, Guerriero C, Matucci A, Cestari T, Scarpa A, Riviera AP, Zanoni G, Tridente G, Andrighetto G. Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response. Immunology 2004; 110:474-81. [PMID: 14632645 PMCID: PMC1783082 DOI: 10.1111/j.1365-2567.2003.01760.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
De novo expression of costimulatory molecules in tumours generally increases their immunogenicity, but does not always induce a protective response against the parental tumour. This issue was addressed in the mouse Sp6 hybridoma model, comparing different immunization routes (subcutaneous, intraperitoneal and intravenous) and doses (0.5 x 10(6) and 5 x 10(6) cells) of Sp6 cells expressing de novo B7-1 (Sp6/B7). The results can be summarized as follows. First, de novo expression of B7-1 rendered Sp6 immunogenic, as it significantly reduced the tumour incidence to < or =15% with all delivery routes and doses tested, whereas wild-type Sp6 was invariably tumorigenic (100% tumour incidence). Second, long-lasting protection against wild-type Sp6 was mainly achieved when immunization with Sp6/B7 was subcutaneous: a dose of 0.5 x 10(6) Sp6/B7 cells elicited protection that was confined to sites in the same anatomical quarter as the immunizing injection. Repeated injections of the same dose extended protection against wild-type Sp6 to other anatomical districts, as well as a single injection of a 10-fold higher dose (5 x 10(6) cells). Finally, Sp6-specific cytotoxic T-lymphocyte activity was detected in draining lymph nodes, and the splenic expansion of Sp6-specific cytotoxic T-lymphocyte precursors quantitatively correlated with the dose of antigen. We conclude that activation of a protective immune response against Sp6 depends on the local environment where the immunogenic form of the 'whole tumour cell antigen' is delivered. The antigen dose regulates the anatomical extent of the protective response.
Collapse
Affiliation(s)
- Silvia Sartoris
- Dipartimento di Patologia, Sezione di Immunologia, Università di Verona, Verona, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Mainiero F, Colombara M, Antonini V, Strippoli R, Merola M, Poffe O, Tridente G, Ramarli D. p38 MAPK is a critical regulator of the constitutive and the beta4 integrin-regulated expression of IL-6 in human normal thymic epithelial cells. Eur J Immunol 2003; 33:3038-48. [PMID: 14579272 DOI: 10.1002/eji.200323931] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Cytokines and adhesion receptors are key mediators in the dialog occurring between thymic epithelial cells (TEC) and thymocytes and regulating T cell maturation and epithelial embryonic differentiation. Among cytokines, IL-6 can be critical in the thymus, fostering proliferation, differentiation and/or survival of both TEC and thymocytes. We have previously reported in human normal TEC that clustering of the laminin receptor alpha6beta4 integrin induced by thymocyte contact or monoclonal antibody-mediated cross-linking regulates IL-6 gene expression via activation of NF-kappaB and NF-IL6 transactivators. Here we show that alpha6beta4 integrin activates p38 mitogen-activated protein kinase (MAPK) and that p38 is essential for IL-6 gene expression. In fact, beta4 cross-linking activated p38 and extracellular signal-regulated kinase (ERK) MAPK, Rac1, p21-activated protein kinase 1 (PAK1) and MAPK kinases (MKK) 3/MKK6. However, pharmacological blockade of p38 or ERK demonstrated that p38 inhibition abrogated both basal and beta4 integrin-induced production of IL-6 preventing NF-kappaB and NF-IL6 activation, whereas ERK inhibition reduced IL-6 production, hampering only NF-kappaB activation. Overall, our results indicate that p38 MAPK and alpha6beta4 integrin, expressed by TEC throughout their life, are critical regulators of the intrathymic availability of a cytokine controlling fate and functions of cells governing development and maintenance of thymic architecture and immune responses.
Collapse
Affiliation(s)
- Fabrizio Mainiero
- Department of Experimental Medicine and Pathology, Institute Pasteur-Fondazione Cenci Bolognetti, University of Rome La Sapienza, Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Zanoni G, Nguyen TMD, Valsecchi M, Gallo G, Tridente G. Prevention and monitoring of adverse events following immunization: the “Green Channel” of the Veneto region in Italy. Vaccine 2003; 22:194-201. [PMID: 14615146 DOI: 10.1016/s0264-410x(03)00566-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Measures to improve vaccine safety are essential for successful immunization programs. Therefore, an activity for vaccine adverse events prevention and surveillance, named the Green Channel, was established in the Veneto ion of Italy in 1992. This report summarizes the results of 10 years activity of a specialized pre-vaccination counseling service, offered to 543 selected at risk individuals referred for prior AEFIs or suspected contraindications (CI) to vaccine administration. Furthermore, data on 1762 AEFIs reported in this region are analyzed and discussed. This joint activity appeared effective and it is proposed as a model.
Collapse
Affiliation(s)
- G Zanoni
- Immunology Unit, Department of Pathology, University of Verona, Policlinico G.B. Rossi, 37134, Verona, Italy.
| | | | | | | | | |
Collapse
|
45
|
Guerriero C, Zoccatelli G, Stefani E, Sartoris S, Cestari T, Riviera AP, Tridente G, Andrighetto G, Chignola R. Myelin basic protein epitopes secreted by human T cells encounter natural autoantibodies in the serum. J Neuroimmunol 2003; 141:83-9. [PMID: 12965257 DOI: 10.1016/s0165-5728(03)00226-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
A previously isolated and characterized IgM monoclonal antibody (mAb 1H6.2) specific to myelin basic protein (MBP) and to MBP epitopes expressed by nonneural cells was used to immunoprecipitate and investigate the expression of MBP epitopes by human T cells. Peripheral T lymphocytes secreted MBP epitopes, and secretion increased in time after mitogen stimulation. Conversely, thymocytes secreted these proteins independently on mitogen stimulation. Specific antibody reactivity (primarily due to IgG3) towards immunoprecipitated MBP epitopes was found in all tested sera from healthy donors and from multiple sclerosis patients as well as in sera from normal human cord blood. Collectively, these data provide insights into the immunological mechanisms leading to central and peripheral tolerance to MBP products.
Collapse
Affiliation(s)
- Chiara Guerriero
- Dipartimento di Patologia, Università di Verona, c/o Policlinico G.B. Rossi, I-37134 Verona, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
|
47
|
Fracasso G, Bellisola G, Cingarlini S, Castelletti D, Prayer-Galetti T, Pagano F, Tridente G, Colombatti M. Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. Prostate 2002; 53:9-23. [PMID: 12210476 DOI: 10.1002/pros.10117] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
BACKGROUND There is presently no effective therapy for relapsing, metastatic, androgen-independent prostate cancer. Immunotherapy with monoclonal antibody-vehicled toxins (Immunotoxins, ITs) may be a promising novel treatment option for the management of prostate cancer in these cases. METHODS Three anti-prostate specific membrane antigen (anti-PSMA) monoclonals (J591, PEQ226.5, and PM2P079.1) were cross-linked to ricin A-chain (RTA; native or recombinant), and their cytotoxic effects were investigated in monolayer and three-dimensional (3-D) cell cultures of prostate carcinoma cells (LNCaP). RESULTS The various Immunotoxins showed effects in the nanomolar range (IC(50s) of 1.6-99 ng/ml) against PSMA+ cells (IC(50) being the concentration inhibiting 50% cell proliferation or protein synthesis). PSMA(-) cell lines were 62- to 277-fold less sensitive to anti-PSMA ITs, evidencing an appreciable therapeutic window. Treatment with J591-smpt-nRTA (0.35-31.7ng/ml) resulted in complete eradication of 3-D tumor micromasses or in 1.46- to 0.35-log reduction of target cells number, depending on the dose. CONCLUSION Anti-PSMA ITs appear to be promising for use in the eradication of small prostate tumor cell aggregates present in tissues and in the bone marrow.
Collapse
Affiliation(s)
- Giulio Fracasso
- Section of Immunology, Department of Pathology, University of Verona, Verona, Italy
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Vella A, Sartoris S, Bambara L, Ortolani R, Carletto A, Biasi D, Stefani E, Tridente G. Cell contact-dependent PMN HLA-DR and CD69 membrane expression induced by autologous mono-lymphocytes and cell lines. Inflammation 2002; 26:143-52. [PMID: 12184627 DOI: 10.1023/a:1016514927365] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Polymorphonuclear granulocytes (PMN) are commonly considered short-lived cells playing an efficient role in primary host defense via phagocytosis and release of cytotoxic compounds and inflammatory cytokines. Purified PMN do not express HLA-DR and CD69 molecules on cell surface, but they can be induced to do so by co-culture with peripheral blood derived mono-lymphocytes. De novo cell-surface expression of HLA-DR was also induced in PMN by co-culture with cell lines of lymphoid phenotype, but not with cell lines of myeloid phenotype. CD69 expression was not induced by co-culture with any of the cell lines used in the present study. In addition, we have observed induction of HLA-DR surface expression on PMN by culture in presence of culture supernatant of one of the cell lines of lymphoid origin, RPMI-8866. Quantitative analysis of HLA-DR and CD69 expression in stimulated PMN allowed us to divide PMN donors in two main groups, one with low expression and the other with high expression of the two molecules. HLA-DR surface expression was not altered by treatment with CHX and BFA, and RT-PCR analysis of total RNA from resting and stimulated PMN with RPMI-8866 supernatant did not detect the presence of any specific HLA-DR and CIITA transcript. Flow-cytometry and fluorescence microscopy analysis of resting PMN revealed the presence of HLA-DR molecules localized in intracellular vesicular-tubular structures. These data show that a reservoir of HLA-DR molecules is stored in the cytoplasm of human resting PMN and can be released to reach cell surface by a mobilization mechanism induced by cell surface interactions with selected cell types and sometimes with molecules released in culture supernatants.
Collapse
Affiliation(s)
- A Vella
- Department of Pathology, University of Verona, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Zanoni G, Martini S, Zedde A, Pagani M, Guarnieri A, Tridente G, Romeo L. Specific immune response to occupational antigens in asymptomatic egg processing workers. Am J Ind Med 2002; 41:490-7. [PMID: 12173374 DOI: 10.1002/ajim.10073] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Hen's egg proteins are known sensitizers and may cause occupational respiratory diseases in exposed workers. The study was conducted in order to ascertain the prevalence of sensitization to work-related antigens in asymptomatic egg processing factory workers. METHODS Clinical history, respiratory function, atopy and the presence of specific antibodies to environmental and occupational antigens were evaluated in 77 workers. A total of 116 unexposed and non-professionally exposed controls were also studied. The antigen concentration of the factory environment was measured. RESULTS Specific IgE and precipitin positivity to egg components was more frequently present in workers than in the two control groups. The egg white protein concentration was higher in the egg breaking area. CONCLUSIONS The avian proteins inhaled induced immune responses to occupational antigens in asymptomatic, professionally exposed subjects. Measures to decrease environmental antigen concentrations and thorough clinical monitoring of sensitized workers are advocated.
Collapse
Affiliation(s)
- Giovanna Zanoni
- Department of Pathology, Section of Immunology, University of Verona, 37134, Italy.
| | | | | | | | | | | | | |
Collapse
|
50
|
Colombatti M, Moretto G, Tommasi M, Fiorini E, Poffe O, Colombara M, Tanel R, Tridente G, Ramarli D. Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors. Glia 2001; 35:224-33. [PMID: 11494413 DOI: 10.1002/glia.1087] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
One of the distinctive features of multiple sclerosis (MS) attacks is homing to the CNS of activated T cells able to orchestrate humoral and cell-based events, resulting in immune-mediated injury to myelin and oligodendrocytes. Of the complex interplay occurring between T cells and CNS constituents, we have examined some aspects of T-cell interactions with astrocytes, the major components of the glial cells. Specifically, we focused on the ability of T cells to regulate the gene expression of interleukin-6 (IL-6) in astrocytes, based on previous evidence showing the involvement of this cytokine in CNS disorders. We found that T-cell adhesion and T-cell soluble factors induce IL-6 gene expression in U251 astrocytes through distinct signaling pathways, respectively, resulting in the activation of NF-kappaB and IRF-1 transcription factors. In a search for effector molecules at the astrocyte surface, we found that alpha3beta1 integrins play a role in NF-kappaB activation induced by T-cell contact, whereas interferon-gamma (IFN-gamma) receptors dominate in IRF-1 induction brought about by T-cell-derived soluble factors. Similar phenomena were observed also in normal fetal astrocyte cultures. We therefore propose that through astrocyte induction, T cells may indirectly regulate the availability of a cytokine which is crucial in modulating fate and behavior of cell populations involved in the pathogenesis of MS inflammatory lesions.
Collapse
Affiliation(s)
- M Colombatti
- Section of Immunology, Department of Pathology, University of Verona, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|